Francesco Cosentino
Solna, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 182 publications
SURPASS-CVOT and the Emerging Biology of Cardiometabolic Benefit.
Journal: Diabetes, obesity & metabolism
Published: July 14, 2026
Vascular Regenerative Cell Flux in Diabetes: Mechanistic and Clinical Implications.
Journal: Diabetes
Published: April 17, 2026
The year in cardiovascular medicine 2025: the top 10 papers in diabetes and metabolic disorders.
Journal: European heart journal
Published: January 30, 2026
Hygiene measures and persistent adherence to SGLT-2 inhibitors minimize risks and maximize cardiorenal protection.
Journal: European heart journal
Published: December 19, 2025
From global guidelines for cardio-kidney-metabolic diseases management to national implementation: perspectives from the guideline workshop taskforce.
Journal: Cardiovascular diabetology
Published: December 03, 2025
Individualizing SGLT2 inhibitors cardiovascular benefit in patients with type 2 diabetes: target trial emulation meets machine learning.
Journal: European journal of preventive cardiology
Published: September 30, 2025
Impact of type 2 diabetes on the relationship between chronic kidney disease and cardiovascular outcomes in heart failure across ejection fraction: observational study from the Swedish heart failure and the Swedish National diabetes registries.
Journal: Cardiovascular diabetology
Published: August 21, 2025
Delivering a European Union cardiovascular health plan: from building momentum to political action.
Journal: European heart journal
Published: August 20, 2025
The year in cardiovascular medicine 2024: the top 10 papers in diabetes and metabolic disorders.
Journal: European heart journal
Published: May 21, 2025
Obesity and its management in primary care setting.
Journal: Journal of diabetes and its complications
Published: April 11, 2025
Association of Ertugliflozin on Kidney Outcomes in People After and Without an Interval Cardiovascular Event: Observations From the VERTIS CV Trial.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: March 12, 2025
Interleukin-1β in circulating mononuclear cells predicts steatotic liver disease improvement after weight loss in subjects with obesity and prediabetes or type 2 diabetes.
Journal: Cardiovascular diabetology
Published: February 07, 2025
Last Updated: 09/26/2026